Ashok Rakhit

2.7k citations
65 papers · 2.2k · h-index 25

Impact in

  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • CAR-T cell therapy research
    • Drug Transport and Resistance Mechanisms
    • Pharmacogenetics and Drug Metabolism

Papers in

    • Colorectal Cancer Treatments and Studies 11
    • Drug Transport and Resistance Mechanisms 9
    • HER2/EGFR in Cancer Research 6
    • Lung Cancer Treatments and Mutations 10
    • Potassium and Related Disorders 4

Ashok Rakhit

64 papers receiving 2.1k citations

Peers

Ashok Rakhit
Comparison fields: 5 of 109
  • Oncology 769
  • Pharmacology 168
  • Immunology 387
  • Pulmonary and Respiratory Medicine 463
  • Hematology 108
Replace Gregory D. Ayers with:
Gregory D. Ayers United States
Akinobu Hamada Japan
Stacy S. Shord United States
Larry J. Schaaf United States
Stijn L.W. Koolen Netherlands
Michael Lind United Kingdom
Masahiro Tsuda Japan
Richard M. Lush United States
Jürgen Venitz United States
Xin Liang China
Ashok Rakhit relative to Gregory D. Ayers United States Gregory D. Ayers's profile →
Citations per field
00.5×1.5×1.8×
Gregory D. Ayers · 1×
Citations per year

Countries citing papers authored by Ashok Rakhit

Since Specialization
Citations

This map shows the geographic impact of Ashok Rakhit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Rakhit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Rakhit more than expected).

Fields of papers citing papers by Ashok Rakhit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Rakhit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Rakhit. The network helps show where Ashok Rakhit may publish in the future.

Co-authors

The 25 scholars most cited alongside Ashok Rakhit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashok Rakhit Line = papers co-authored together Ashok Rakhit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.
1998196
2 2006191
3 2005189
4
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.
1998138
5 2007111
6 201698
7
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer.
199992
8 200184
9 200683
10 200878
11 200173
12 198648
13 199347
14 201442
15 199941
16 200838
17 200238
18 199237
19 199636
20 199932

About Ashok Rakhit

Ashok Rakhit is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 65 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (10 papers), Drug Transport and Resistance Mechanisms (9 papers), HER2/EGFR in Cancer Research (6 papers), Ion channel regulation and function (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Potassium and Related Disorders (4 papers). The work is most often cited by research in Oncology (769 citations), Pharmacology (168 citations), Immunology (387 citations), Pulmonary and Respiratory Medicine (463 citations) and Hematology (108 citations). Ashok Rakhit has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Marta Hamilton, Bert L. Lum, Scott Fettner, Robert J. Motzer, Michael Pantze, Steve Eppler, R Nadeau, Jie Ling, Ronald M. Bukowski and Myriam Riek. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Pharmaceutical Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact